CAT No: CP27430
CAS No:74844-91-0
Synonyms/Alias:74844-91-0;N-Boc-trans-4-hydroxy-L-prolinemethylester;Boc-Hyp-OMe;(2S,4R)-1-tert-butyl2-methyl4-hydroxypyrrolidine-1,2-dicarboxylate;1-tert-butyl2-methyl(2S,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate;BOC-HYDROXYPROLINE-OME;BOC-L-Hydroxyprolinemethylester;MFCD00076981;Methylcis-1-Boc-4-hydroxy-D-prolinate;Methyltrans-1-Boc-4-hydroxy-L-prolinate;trans-1-(tert-Butoxycarbonyl)-4-hydroxy-L-prolinemethylester;N-BOC-trans-4-hydroxyl-L-prolinemethylester;O1-TERT-BUTYLO2-METHYL(2S,4R)-4-HYDROXYPYRROLIDINE-1,2-DICARBOXYLATE;N-(tert-Butoxycarbonyl)-trans-hydroxy-L-prolinemethylester;N-(tert-Butoxycarbonyl)-trans-4-hydroxy-L-prolineMethylEster;(2S,4R)-1-(tert-Butoxycarbonyl)-4-hydroxy-2-(methoxycarbonyl)pyrrolidine;Boc-Hyp.OMe;Boc-trans-Hyp-Ome;Boc-trans-4-Hydroxy-L-prolinemethylester;L-BOCHPROME;N-BOC-4-HYDROXY-L-PROLINEMETHYLESTER;PubChem18619;BOC-L-HYP-OME;(2S,4R)-4-Hydroxy-1,2-pyrrolidinedicarboxylicacid1-tert-butyl2-methylesterhydrochloride;AC1MC25H
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.